文献速递腹部CT

CT栖息地影像组学预测胃癌HER2表达

Prediction of human epidermal growth factor receptor 2 expression in gastric carcinoma using whole-tumor habitats-based and conventional CT radiomics.
PubMed 文献 · Eur J Radiol · 2026-08-26

本研究回顾性纳入两个中心328例胃癌患者术前增强CT,提取全瘤常规影像组学特征和基于K-means聚类的三个栖息地亚区域特征,使用SVM、XGBoost、LightGBM分类器建模。结果显示联合模型对HER2表达的预测效能优于单一模型,提示其可作为术前预测HER2状态的影像标志物。

要点

  • 联合全瘤栖息地与常规影像组学模型的预测效能最优
  • 外部验证队列中联合模型SVM的AUC为0.725
  • 术前增强CT可用于无创预测胃癌HER2表达状态

核心结论

  • 联合栖息地影像组学与常规影像组学的模型可作为胃癌HER2表达状态的预测性影像标志物。
  • 在训练、内部验证和外部验证队列中,联合模型的预测效能均优于单一栖息地模型或常规影像组学模型。

研究设计与样本

  • 回顾性研究,共纳入328例胃癌患者,均行术前增强CT检查,来自两个中心。
  • 中心1的278例随机分为训练队列222例和内部验证队列56例,中心2的50例作为外部验证队列。
  • 影像组学建模采用支持向量机(SVM)、极限梯度提升(XGBoost)和轻量梯度提升机(LightGBM)三种分类器。

关键影像表现/征象

  • 从全瘤提取常规CT影像组学特征,并采用K-means聚类将全瘤划分为三个栖息地亚区域后提取栖息地影像组学特征。

诊断标准与关键数值

  • SVM联合模型在训练、内部验证和外部验证队列的AUC分别为0.956、0.847和0.725。
  • SVM栖息地模型对应三个队列的AUC分别为0.911、0.835和0.685,SVM常规模型分别为0.792、0.771和0.614。
  • XGBoost联合模型在内部验证和外部验证队列的AUC分别为0.784和0.745,LightGBM联合模型分别为0.804和0.708。
  • 多数比较中联合模型与单一模型的AUC差异具有统计学意义(p<0.05)。

临床应用与阅片要点

  • 胃癌术前增强CT的影像组学分析可用于无创评估HER2表达状态,辅助临床治疗决策。
  • 阅片时可关注肿瘤内部异质性亚区域特征,联合全瘤特征可能提高预测稳定性。

局限性

  • 该研究为回顾性设计,两个中心的样本量不一致,外部验证队列仅50例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate feasibility of combination of whole-tumor subregion-based CT habitat and conventional radiomics to improve preoperative identifying human epidermal growth factor receptor 2 (HER2) expression in gastric carcinoma (GC).

METHODS: 328 patients with GC undergoing preoperative contrast-enhanced CT were retrospectively included from two centers. Patients from Center 1 (n = 278) were randomly divided into training (n = 222) and internal-validation (n = 56) cohorts, and an external-validation cohort comprised 50 patients from Center 2. Conventional CT radiomics features were extracted from whole-tumor. Habitat radiomics features were from three habitat subregions of whole-tumor using K-means clustering. The habitats-based and conventional radiomics models, and the combined model by integrating previous features for predicting HER2 status were created using Support Vector Machine (SVM) classifiers followed with eXtreme Gradient Boosting (XGBoost), and Light Gradient Boosting Machine (LightGBM). Models' performance was evaluated using area under the receiver operating characteristic curve (AUC) and Delong test.

RESULTS: For SVM classifiers, the combined model showed better predictability than the habitats-based or conventional model (AUC: 0.956 vs. 0.911 or 0.792, 0.847 vs. 0.835 or 0.771, and 0.725 vs. 0.685 or 0.614) in training, internal- and external-validation cohorts, which was confirmed using XGBoost (AUC: 0.784 vs. 0.754 or 0.702, and 0.745 vs. 0.696 or 0.638) and LightGBM (AUC: 0.804 vs. 0.748 or 0.685, and 0.708 vs. 0.699 or 0.553) classifiers in internal- and external-validation cohorts, respectively (p < 0.05 for most comparisons).

CONCLUSION: The combined model could serve as a predictive biomarker of HER2 expression prediction in GC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang, Wen, Lu, et al. Prediction of human epidermal growth factor receptor 2 expression in gastric carcinoma using whole-tumor habitats-based and conventional CT radiomics. Eur J Radiol. 2026. PMID: 42664726. doi:10.1016/j.ejrad.2026.113185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。